Phi Med Europe is a medical technology Co. founded in 2011 in Barcelona, Spain.
The strength of Phi Med Europe lies in its multi-disciplinary team skills, competencies and experiences put together to develop a world class medical devices.
We are empowering healthcare through the implementation of technology that quantify and improves the diagnosis and monitoring of Sensory Neurological Dysfunction.
Launched in the market our main product NerveCheck Master, for the quantification and detection in an early stage of a common complication in diabetic patients as it is diabetic foot.
1 amputation every 30 seconds around the world, due to diabetic complication.
Most important, 80% of those amputations could be avoided.
Get NerveChecked.
Company Details
- Founded
- -
- Address
- Carrer De Sant Antoni Maria Claret,, 167,spain
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.phimedeurope.com
- Keywords
- Neurology, Endocrinology, Product Development, R+D+i, Manufacturing, Sensory Loss, Diabetic Pain, Quantitative Sensory Testing.
- HQ
- Barcelona, Barcelona
Phi Med Europe Questions
Phi Med Europe's website is http://www.phimedeurope.com
Phi Med Europe's LinkedIn profile is https://es.linkedin.com/company/phi-med-europe-s.l.
Phi Med Europe's industry is
Biotechnology Research
Phi Med Europe's top competitors are
Clear.bio,
Boydsense,
Spotlight-Aq,
Diabetes Cockpit App,
Fada Medical,
Go-Pen Aps,
Provigate, Inc,
Onetwo Analytics,
Glucotrack,
Digital Oxygen.
Phi Med Europe's categories are Biotechnology Research
Phi Med Europe's founding year is 2011
